Snowball logo
logo
REKA

Rekah Pharmaceutical Industry Ltd

REKA TA
10.66-0.02  (0.19%)
Estimate
EPS
-1.62
Beta
0.114
Growth
Revenue, YoY
4.15%
Net income, YoY
-19.29%
FCF, YoY
-38.75%
About the company
Ticker
REKA
ISIN
IL0010810096
Country
Israel
Sector (GICS)
Healthcare
Rekah Pharmaceutical Industry Ltd. engages in the manufacture, marketing, sale, and distribution of pharmaceuticals, cosmetics, vitamins and nutritional supplements, and medical devices in Israel. The company offers steroids, antibiotics, and ophthalmic products, as well as dermo-cosmetics products. Its portfolio of products comprise Rx and OTC drugs, and medical devices used in various therapeutic fields, such as urinary tract pain, steroid anti-inflammatories, cough, expectoration and bronchitis, motion sickness, runny nose and congestion, skin disinfection, wounds, burns and insect bites, eye infections, glaucoma, dryness, allergies, fever and pain relief, mouth, depression and anxiety, muscle and joint pain, antibiotics, fungal infections, anemia and nutritional deficits, ear pain, babies and children, etc. The company was founded in 1947 and is based in Holon, Israel.

Frequently asked questions

What sector does Rekah Pharmaceutical Industry Ltd (REKA) operate in?

Rekah Pharmaceutical Industry Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is Rekah Pharmaceutical Industry Ltd (REKA) current stock price?

As of the latest data, Rekah Pharmaceutical Industry Ltd stock price is ₪10.66, with a previous close of ₪10.68. Rekah Pharmaceutical Industry Ltd lost -₪0.02 in the last trading session, representing a -0.19% loss.

What is Rekah Pharmaceutical Industry Ltd (REKA) current market capitalization?

Rekah Pharmaceutical Industry Ltd market cap is approximately 121.68 million.

What is Rekah Pharmaceutical Industry Ltd (REKA) Earnings Per Share (EPS)?

The trailing EPS is -₪1.62.

What is Rekah Pharmaceutical Industry Ltd (REKA) EBITDA?

Rekah Pharmaceutical Industry Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 6.59 million.

Does Rekah Pharmaceutical Industry Ltd (REKA) pay dividends?

No. Rekah Pharmaceutical Industry Ltd does not pay a dividend.

What is Rekah Pharmaceutical Industry Ltd (REKA) beta (volatility) score?

Rekah Pharmaceutical Industry Ltd has a beta of 0.114, indicating lower volatility than the overall market.